UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
- 1 October 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 326 (8459) , 800-801
- https://doi.org/10.1016/s0140-6736(85)90794-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal womenCalcified Tissue International, 1984
- An easy and reliable method for determination of urinary hydroxyprolineClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1984
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal WomenClinical Science, 1978
- DIAGNOSTIC PROCEDURES IN DISORDERS OF CALCIUM METABOLISMClinical Endocrinology, 1978
- Prospective trial of oestrogen and calcium in postmenopausal women.BMJ, 1977
- Bone remodeling and calcium metabolism: A correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's diseaseMetabolism, 1977
- Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosisJournal of Clinical Investigation, 1972